FIELD: biotechnology.
SUBSTANCE: invention relates to versions of keratin and can be used in medicine when producing a drug having antipyretic, analgesic, antitussive, expectorant, anticonvulsant and antiepileptic action.
EFFECT: invention provides the therapeutic use of keratin, having efficacy in reducing a rise in body temperature in a fever model in SD rats and prolonging the latency of seizures in class III epilepsy in mice; expectorant action in method with release of phenol red in mice; antitussive action in a method for stimulating coughing with an aqueous solution of ammonia in mice and a tendency to reduce the number of writhing in mice and potential analgesic action in acetic acid-induced writhing in ICR mice.
10 cl, 3 dwg, 9 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| KERATIN BD-11, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2825992C1 |
| KERATIN BD-13, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2825991C1 |
| KERATIN BD-6, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2825993C1 |
| KERATIN BD-3, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2815384C1 |
| KERATIN BD-1, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2825994C1 |
| KERATIN BD-4, PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF | 2020 |
|
RU2824893C1 |
| ANTI-αvβ8 ANTIBODIES AND COMPOSITIONS AND THEIR USE | 2019 |
|
RU2812478C2 |
| GENE THERAPY FOR THE TREATMENT OF HEMOPHILIA A | 2017 |
|
RU2762257C2 |
| THERAPEUTIC COMPOUNDS AND METHODS | 2016 |
|
RU2770001C2 |
| CHIMERIC HUMAN MESOTHELIOGEN ANTIGEN RECEPTORS AND USE THEREOF | 2014 |
|
RU2714902C2 |
